Grupo para la caracterización molecular de las neoplasias hematológicas
Hokkaido University Hospital
Sapporo, JapónPublications in collaboration with researchers from Hokkaido University Hospital (1)
2022
-
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
Nature Medicine, Vol. 28, Núm. 2, pp. 325-332